May 27, 2016

Canadian drugmaker Valeant reportedly rejects takeover bid from Takeda

Valeant Pharmaceuticals International Inc. received a takeover approach this spring from Takeda Pharmaceutical Co. and investment firm TPG, which it rejected, according to the Wall Street Journal. The specialty drugmaker has been struggling to revive itself after its business model and drug pricing practices ...

Japan takes aim at ballooning drug prices as costs strain health budget

Feb 8, 2016

Japan takes aim at ballooning drug prices as costs strain health budget

When two of the world’s biggest pharmaceutical companies announced a tie-up in Japan, its $78 billion drug industry took note. In November, the nation’s largest drugmaker, Takeda Pharmaceutical Co., said it’d separate its off-patent products and share its extensive domestic distribution network with Israel’s ...

U.S. jury orders Takeda to pay $6 billion over Actos diabetes drug

Apr 8, 2014

U.S. jury orders Takeda to pay $6 billion over Actos diabetes drug

A jury in Louisiana on Monday ordered Takeda Pharmaceutical Co. to pay $6 billion in punitive damages, acknowledging that Japan’s largest drugmaker concealed the risks of cancer associated with its diabetes drug Actos, according to Takeda and U.S. media reports. In the case, Terrence ...

Takeda breaks tradition with outsider at helm

Dec 4, 2013

Takeda breaks tradition with outsider at helm

by

Takeda Pharmaceutical Co., the more than 230-year-old drugmaker, is starting to make a practice of breaking with tradition. The firm last week named Christophe Weber, a French national who has never worked at Takeda, as chief operating officer and the planned successor to CEO ...